Surrey Heartlands

Joint Formulary & PAD

Nafarelin acetate - Transgender Health - adults

You are here : Home > Formulary Search > Nafarelin acetate - Transgender Health - adults

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Amber
Formulations :
  • Nasal spray
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
Guidelines BNF SPC
Un
Restrictions / Comments :

Documentation

Education material (for healthcare personnel)
Gender Identity Training and Information Resources

PAD Profile

ChemicalSubstance :
Nafarelin acetate
Indication :
Transgender Health - adults
Group Name :
Keywords :
gender dysphoria, gonadorelin analogues, GnRH analogues, LHRH analogues, hormone therapy, gender reassignment, sex change, gender incongruence, transsexuals, transgender, hormone manipulation, puberty supression, masculinisation, feminisation
Brand Names Include :
Synarel
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Transgender Health - adults
Supporting Documents :
1

Other Indications

Below are listed other indications that Nafarelin acetate is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Transgender Health - adults.

Committee Recommendations (2)

06 Dec 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

After undertaking a review of previous decisions and resources relating to transgender health, the APC agreed an AMBER status for oestrogen, testosterone, cyproterone, finasteride, GnRH & medroxyprogeterone when used in adults. 

Primary care initiation of these drugs is supported by the APC if the prescriber is competent to exercise their share of clinical responsibility and is assured that the shared care protocol provides enough information for them to discharge their responsibilities safely.

A guide to support primary care prescribing for people who access gender identity services was also agreed by the APC. 

The guide includes information on children and young people, requests to prescribe, shared care, on-going care and private providers.

02 Aug 23 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Integrated Care System  Area Prescribing Committee have reviewed the traffic light status' of treatments used for transgender health in adults.

Nafarelin (Nasal Spray) has been given an AMBER traffic light status.